Hyaluronic acid-functionalized mesoporous silica nanoparticles for efficient photodynamic therapy of cancer cells

Photodiagnosis and Photodynamic Therapy

Volumn 9, Issue 3, 2012, Pages 256-260

  Gary Bobo, Magali ^a   Brevet, David ^b   Benkirane Jessel, Nadia ^c,d   Raehm, Laurence ^b   Maillard, Philippe ^b,e   Garcia, Marcel ^a   Durand, Jean Olivier ^b  

^a UNIVERSITÉ DE MONTPELLIER   (France)

^b CNRS   (France)

^c University of Strasbourg   (France)

^d UNIVERSITÉ DE STRASBOURG   (France)

^e INSTITUT CURIE   (France)

Author keywords

Hyaluronic acid; Layer by layer; Mesoporous silica nanoparticles; Photodynamic therapy

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID; MESOPOROUS SILICA NANOPARTICLE; NANOPARTICLE; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CELL STRAIN HCT116; COLORECTAL CANCER; CONTROLLED STUDY; ENDOCYTOSIS; HUMAN; HUMAN CELL; INCUBATION TEMPERATURE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

APOPTOSIS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; HUMANS; HYALURONIC ACID; NANOCAPSULES; PHOTOCHEMOTHERAPY; POROSITY; SILICON DIOXIDE; TREATMENT OUTCOME;

EID: 84865980140     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2011.12.010     Document Type: Article

References (47)

1. Boulaiz H., Alvarez P.J., Ramirez A., et al. Nanomedicine: application areas and development prospects. Int J Mol Sci 2011, 12:3303-3321.
2. Barreto J.A., O'Malley W., Kubeil M., Graham B., Stephan H., Spiccia L. Nanomaterials: applications in cancer imaging and therapy. Adv Mater 2011, 23:H18-H40.
3. Bae K.H., Chung H.J., Park T.G. Nanomaterials for cancer therapy and imaging. Mol Cells 2011, 31:295-302.
4. Haque N., Khalel R.R., Parvez N., et al. Nanotechnology in cancer therapy: a review. J Chem Pharm Res 2010, 2:161-168.
5. Anajwala C.C., Jani G.K., Swamy S.M.V. Current trends of nanotechnology for cancer therapy. Int J Pharm Sci Nanotechnol 2010, 3:1043-1056.
6. Danhier F., Feron O., Preat V. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release 2010, 148:135-146.
7. Firczuk M., Winiarska M., Szokalska A., et al. Approaches to improve photodynamic cherapy of cancer. Front Biosci, Landmark Ed 2011, 16:208-224.
8. Robertson C.A., Evans D.H., Abraharnse H. Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT. J Photochem Photobiol B: Biol 2009, 96:1-8.
9. Chatterjee D.K., Fong L.S., Zhang Y. Nanoparticles in photodynamic therapy: an emerging paradigm. Adv Drug Deliv Rev 2008, 60:1627-1637.
10. Bechet D., Couleaud P., Frochot C., Viriot M.-L., Guillemin F., Barberi-Heyob M. Nanoparticles as vehicles for delivery of photodynamic therapy agents. Trends Biotechnol 2008, 26:612-621.
11. Nann T. Nanoparticles in photodynamic therapy. Nano Biomed Eng 2011, 3:137-143.
12. Couleaud P., Morosini V., Frochot C., Richeter S., Raehm L., Durand J.O. Silica-based nanoparticles for photodynamic therapy applications. Nanoscale 2010, 2:1083-1095.
13. Vivero-Escoto J.L., Slowing I.I., Trewyn B.G., Lin V.S.Y. Mesoporous silica nanoparticles for intracellular controlled drug delivery. Small 2010, 6:1952-1967.
14. Rosenholm J.M., Sahlgren C., Linden M. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles - opportunities & challenges. Nanoscale 2010, 2:1870-1883.
15. Coti K.K., Belowich M.E., Liong M., et al. Mechanised nanoparticles for drug delivery. Nanoscale 2009, 1:16-39.
16. He Q., Shi J. Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility. J Mater Chem 2011, 21:5845-5855.
17. Rosenholm J., Sahlgren C., Linden M. Cancer-cell targeting and cell-specific delivery by mesoporous silica nanoparticles. J Mater Chem 2010, 20:2707-2713.
18. Yang Y., Song W.X., Wang A.H., Zhu P.L., Fei J.B., Li J.B. Lipid coated mesoporous silica nanoparticles as photosensitive drug carriers. Phys Chem Chem Phys 2010, 12:4418-4422.
19. Guo H., Qian H., Idris N.M., Zhang Y. Singlet oxygen-induced apoptosis of cancer cells using upconversion fluorescent nanoparticles as a carrier of photosensitizer. Nanomedicine 2010, 6:486-495.
20. Cheng S.-H., Lee C.-H., Chen M.-C., et al. Tri-functionalization of mesoporous silica nanoparticles for comprehensive cancer theranostics - the trio of imaging, targeting and therapy. J Mater Chem 2010, 20:6149-6157.
21. Tu H.-L., Lin Y.-S., Hung Y., Lo L.-W., Chen Y.-F., Mou C.-Y. In vitro studies of functionalized mesoporous silica nanoparticles for photodynamic therapy. Adv Mater 2009, 21:172-174.
22. Cheng S.-H., Lee C.-H., Yang C.-S., Tseng F.-G., Mou C.-Y., Lo L.-W. Mesoporous silica nanoparticles functionalized with an oxygen-sensing probe for cell photodynamic therapy: potential cancer theranostics. J Mater Chem 2009, 19:1252-1257.
23. Hocine O., Gary-Bobo M., Brevet D., et al. Silicalites and mesoporous silica nanoparticles for photodynamic therapy. Int J Pharm 2010, 402:221-230.
24. Brevet D., Gary-Bobo M., Raehm L., et al. Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy. Chem Commun 2009, 1475-1477.
25. Lapcik L., De Smedt S., Demeester J., Chabrecek P. Hyaluronan: preparation, structure, properties, and applications. Chem Rev 1998, 98:2663-2684.
26. Fan H., Tao H., Wu Y., Hu Y., Yan Y., Luo Z. TGF-beta 3 immobilized PLGA-gelatin/chondroitin sulfate/hyaluronic acid hybrid scaffold for cartilage regeneration. J Biomed Mater Res A 2010, 95A:982-992.
27. Gerecht S., Burdick J.A., Ferreira L.S., Townsend S.A., Langer R., Vunjak-Novakovic G. Hyaluronic acid hydrogen for controlled self-renewal and differentiation of human embryonic stem cells. PNAS 2007, 104:11298-11303.
28. Pitarresi G., Palumbo F.S., Albanese A., Fiorica C., Picone P., Giammona G. Self-assembled amphiphilic hyaluronic acid graft copolymers for targeted release of antitumoral drug. J Drug Target 2010, 18:264-276.
29. Li F., Bae B.-C., Na K. Acetylated hyaluronic acid/photosensitizer conjugate for the preparation of nanogels with controllable phototoxicity: synthesis, characterization, autophotoquenching properties, and in vitro phototoxicity against He La cells. Bioconjug Chem 2010, 21:1312-1320.
30. Kamat M., El-Boubbou K., Zhu D.C., et al. Hyaluronic acid immobilized magnetic nanoparticles for active targeting and imaging of macrophages. Bioconjug Chem 2010, 21:2128-2135.
31. Lee Y., Lee H., Kim Y.B., et al. Bioinspired surface immobilization of hyaluronic acid on monodisperse magnetite nanocrystals for targeted cancer imaging. Adv Mater 2008, 20:4154-4157.
32. Kim K.S., Hur W., Park S.-J., et al. Bioimaging for targeted delivery of hyaluronic acid derivatives to the livers in cirrhotic mice using quantum dots. ACS Nano 2010, 4:3005-3014.
33. Choi K.Y., Chung H., Min K.H., et al. Self-assembled hyaluronic acid nanoparticles for active tumor targeting. Biomaterials 2010, 31:106-114.
34. Choi K.Y., Min K.H., Na J.H., et al. Self-assembled hyaluronic acid nanoparticles as a potential drug carrier for cancer therapy: synthesis, characterization, and in vivo biodistribution. J Mater Chem 2009, 19:4102-4107.
35. Lee H., Lee K., Kim I.K., Park T.G. Synthesis, characterization, and in vivo diagnostic applications of hyaluronic acid immobilized gold nanoprobes. Biomaterials 2008, 29:4709-4718.
36. Kim J., Kim K.S., Jiang G., et al. In vivo real-time bioimaging of hyaluronic acid derivatives using quantum dots. Biopolymers 2008, 89:1144-1153.
37. Decher G. Fuzzy nanoassemblies: toward layered polymeric multicomposites. Science 1997, 277:1232-1237.
38. Jessel N., Atalar F., Lavalle P., et al. Bioactive coatings based on a polyelectrolyte multilayer architecture functionalized by embedded proteins. Adv Mater 2003, 15:692-695.
39. Slowing I., Trewyn B.G., Lin V.S.Y. Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. J Am Chem Soc 2006, 128:14792-14793.
40. Lu J., Liong M., Sherman S., et al. Mesoporous silica nanoparticles for cancer therapy: energy-dependent cellular uptake and delivery of paclitaxel to cancer cells. NanoBiotechnology 2007, 3:89-95.
41. Huang D.-M., Hung Y., Ko B.-S., et al. Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking. FASEB J 2005, 19:2014-2016.
42. Lu J., Liong M., Zink J.I., Tamanoi F. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs. Small 2007, 3:1341-1346.
43. Wan X., Zhang G., Liu S. pH-disintegrable polyelectrolyte multilayer-coated mesoporous silica nanoparticles exhibiting triggered co-release of cisplatin and model drug molecules. Macromol Rapid Commun 2011, 32:1082-1089.
44. Meng H., Xue M., Xia T., et al. Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model. ACS Nano 2011, 5:4131-4144.
45. Mamaeva V., Rosenholm J.M., Bate-Eya L.T., et al. Mesoporous silica nanoparticles as drug delivery systems for targeted inhibition of notch signaling in cancer. Mol Ther 2011, 19:1538-1546.
46. Gary-Bobo M., Mir Y., Rouxel C., et al. Mannose-functionalized mesoporous silica nanoparticles for efficient two-photon photodynamic therapy of solid tumors. Angew Chem Int Ed 2011, 50:11425-11429.
47. Lu J., Liong M., Li Z., Zink J.I., Tamanoi F. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small 2010, 6:1794-1805.